These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35468186)

  • 1. UK pharmacists' experiences and perceptions of conflict between personal ethical commitments and professional obligations, as set out in professional guidance.
    Fovargue S; Neal M
    Int J Pharm Pract; 2022 Jun; 30(3):241-246. PubMed ID: 35468186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring pharmacists' views surrounding conscientious objection to abortion and implications in practice.
    Maxwell C; McKendrick J; Hanlon C; Penson P; Fleming V
    Int J Pharm Pract; 2021 May; 29(3):258-264. PubMed ID: 33876827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving pharmacy practice in relation to complementary medicines: a qualitative study evaluating the acceptability and feasibility of a new ethical framework in Australia.
    Popattia AS; Hattingh L; La Caze A
    BMC Med Ethics; 2021 Jan; 22(1):3. PubMed ID: 33407396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring Ethical Pharmacy Practice in Jordan.
    Fino LB; Basheti IA; Chaar BB
    Sci Eng Ethics; 2020 Oct; 26(5):2809-2834. PubMed ID: 32533448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital pharmacists' ethical exposure and decision-making.
    So B; Tuche M; King MA; Hope DL; La Caze A; Hattingh HL
    Res Social Adm Pharm; 2021 Feb; 17(2):372-380. PubMed ID: 32284299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives of community pharmacists on conscientious objection to provide pharmacy services: A theory informed qualitative study.
    Gülpınar G; Keleş Ş; Yalım NY
    J Am Pharm Assoc (2003); 2021; 61(4):373-381.e1. PubMed ID: 33895101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacy practitioners' lived experiences of culture in multicultural Australia: From perceptions to skilled practice.
    Fejzic J; Barker M
    PLoS One; 2019; 14(6):e0217673. PubMed ID: 31216322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
    Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
    Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards the implementation of breastfeeding-related health services in community pharmacies: Pharmacists' perspectives.
    Sim TF; Hattingh HL; Sherriff J; Tee LBG
    Res Social Adm Pharm; 2017; 13(5):980-988. PubMed ID: 28325528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enablers and challenges to pharmacy practice change in Kuwait hospitals: a qualitative exploration of pharmacists' perceptions.
    Katoue MG
    J Eval Clin Pract; 2021 Apr; 27(2):272-279. PubMed ID: 32929812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy.
    Latif A; Waring J; Watmough D; Barber N; Chuter A; Davies J; Salema NE; Boyd MJ; Elliott RA
    Res Social Adm Pharm; 2016; 12(6):966-989. PubMed ID: 26806858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical, religious and factual beliefs about the supply of emergency hormonal contraception by UK community pharmacists.
    Cooper RJ; Bissell P; Wingfield J
    J Fam Plann Reprod Health Care; 2008 Jan; 34(1):47-50. PubMed ID: 18201407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacists in general practice: a qualitative interview case study of stakeholders' experiences in a West London GP federation.
    Ryan K; Patel N; Lau WM; Abu-Elmagd H; Stretch G; Pinney H
    BMC Health Serv Res; 2018 Apr; 18(1):234. PubMed ID: 29609603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solidarity or dissonance? A systematic review of pharmacist and GP views on community pharmacy services in the UK.
    Hindi AMK; Jacobs S; Schafheutle EI
    Health Soc Care Community; 2019 May; 27(3):565-598. PubMed ID: 30047617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mifepristone (RU486) in Australian pharmacies: the ethical and practical challenges.
    Lee RY; Moles R; Chaar B
    Contraception; 2015 Jan; 91(1):25-30. PubMed ID: 25248673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nature of conflict in community pharmacy - A pilot study of pharmacists' experiences during the COVID-19 pandemic.
    Lam W; Mey A; King MA; Woods P
    Res Social Adm Pharm; 2022 Jul; 18(7):3164-3173. PubMed ID: 34521587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacists' professional practices for complementary medicines: a qualitative study in New Zealand.
    Barnes J; Butler R
    Int J Clin Pharm; 2020 Aug; 42(4):1109-1117. PubMed ID: 32686048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical responsibilities of pharmacists when selling complementary medicines: a systematic review.
    Salman Popattia A; Winch S; La Caze A
    Int J Pharm Pract; 2018 Apr; 26(2):93-103. PubMed ID: 29315916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacists' views on Indigenous health: is there more that can be done?
    Stoneman J; Taylor SJ
    Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community pharmacists' opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China.
    Xi X; Huang Y; Lu Q; Ung COL; Hu H
    Int J Clin Pharm; 2019 Apr; 41(2):478-487. PubMed ID: 30864081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.